Physician profile
Jennifer Katz
NPI 1144454976
$3,784.76
in general payments reported to CMS, 2019-2025
10 companies · $77.16 in 2025
The $77.16 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $20.75 · 2021: $36.17 · 2022: $2,125 · 2023: $1,264 · 2024: $70.54 · 2025: $77.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876 · Travel and Lodging: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.36 |
| Travel and Lodging | $535.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $3,124.47 | 2022-2023 | |
| Abbvie INC. | $330.57 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.17 | 2019-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $78.23 | 2023 | Gattex |
| Intercept Pharmaceuticals, INC. | $38.79 | 2021-2023 | Ocaliva |
| Boston Scientific Corporation | $27.25 | 2024 | |
| Janssen Biotech, INC. | $21.81 | 2021 | |
| Conmed Corporation | $21.61 | 2025 | |
| Philips North America LLC | $19.36 | 2022 | |
| Celgene Corporation | $13.50 | 2023 | Zeposia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.